Newsbenzinga
Xenetic Biosciences Announces Deal To Acquire Santersus AG In All-Stock Share Exchange; Xenetic Holders To Own About 15%, Santersus Holders About 85%; To Trade As Santersus Bio Under Ticker SNTS
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…